Free Shipping on All Orders $75 Or More!

Your Trusted Brand for Over 35 Years

Health Protocols

Stress Management


  1. Dhabhar FS. Effects of stress on immune function: the good, the bad, and the beautiful. Immunol Res. May 2014;58(2-3):193-210.
  2. Duric V, Clayton S, Leong ML, Yuan LL. Comorbidity Factors and Brain Mechanisms Linking Chronic Stress and Systemic Illness. Neural Plast. 2016;2016:5460732.
  3. Herman JP, McKlveen JM, Ghosal S, et al. Regulation of the Hypothalamic-Pituitary-Adrenocortical Stress Response. Compr Physiol. Mar 15 2016;6(2):603-621.
  4. Househam AM, Peterson CT, Mills PJ, Chopra D. The Effects of Stress and Meditation on the Immune System, Human Microbiota, and Epigenetics. Adv Mind Body Med. Fall 2017;31(4):10-25.
  5. McEwen BS. In pursuit of resilience: stress, epigenetics, and brain plasticity. Ann N Y Acad Sci. Jun 2016;1373(1):56-64.
  6. Worthen M, Cash E. Stress Management. StatPearls. Treasure Island (FL): StatPearls Publishing LLC.; 2018.
  7. Dantzer B, Fletcher QE, Boonstra R, Sheriff MJ. Measures of physiological stress: a transparent or opaque window into the status, management and conservation of species? Conservation Physiology. 2014;2(1):cou023-cou023.
  8. Kamin HS, Kertes DA. Cortisol and DHEA in development and psychopathology. Horm Behav. Mar 2017;89:69-85.
  9. Tsigos C, Kyrou I, Kassi E, Chrousos GP. Tsigos C, Kyrou I, Kassi E, et al. Stress, Endocrine Physiology and Pathophysiology. [Updated 2016 Mar 10]. In: De Groot LJ, Chrousos G, Dungan K, et al., editors. Endotext [Internet]. South Dartmouth (MA):, Inc.; 2000-. Available from: Accessed 10/26/2018. Endotext. South Dartmouth (MA):, Inc.; 2016.
  10. Harrell CS, Gillespie CF, Neigh GN. Energetic stress: The reciprocal relationship between energy availability and the stress response. Physiol Behav. Nov 1 2016;166:43-55.
  11. Rao R. Hypothalamic-Pituitary-Adrenal Axis Programming after Recurrent Hypoglycemia during Development. J Clin Med. Sep 2015;4(9):1729-1740.
  12. Wood SK, Valentino RJ. The brain norepinephrine system, stress and cardiovascular vulnerability. Neurosci Biobehav Rev. Mar 2017;74(Pt B):393-400.
  13. Kritikou I, Basta M, Vgontzas AN, et al. Sleep apnoea and the hypothalamic-pituitary-adrenal axis in men and women: effects of continuous positive airway pressure. Eur Respir J. Feb 2016;47(2):531-540.
  14. Shin W, Jen R, Li Y, Malhotra A. Tailored treatment strategies for obstructive sleep apnea. Respir Investig. Jan 2016;54(1):2-7.
  15. Spiers JG, Chen HJ, Sernia C, Lavidis NA. Activation of the hypothalamic-pituitary-adrenal stress axis induces cellular oxidative stress. Front Neurosci. 2014;8:456.
  16. Gadek-Michalska A, Tadeusz J, Rachwalska P, Bugajski J. Cytokines, prostaglandins and nitric oxide in the regulation of stress-response systems. Pharmacol Rep. 2013;65(6):1655-1662.
  17. Spencer RL, Deak T. A users guide to HPA axis research. Physiol Behav. Sep 1 2017;178:43-65.
  18. McEwen BS, Nasca C, Gray JD. Stress Effects on Neuronal Structure: Hippocampus, Amygdala, and Prefrontal Cortex. Neuropsychopharmacology. Jan 2016;41(1):3-23.
  19. Charoensri S, Chailurkit L, Muntham D, Bunnag P. Serum dehydroepiandrosterone sulfate in assessing the integrity of the hypothalamic-pituitary-adrenal axis. J Clin Transl Endocrinol. Mar 2017;7:42-46.
  20. JCCL. Jo Cox Commission of Loneliness: A Call to Action. Available at Published 2017. Accessed 11/04/2018. 2017.
  21. Pimlott N. The ministry of loneliness. Can Fam Physician. Mar 2018;64(3):166.
  22. Leigh-Hunt N, Bagguley D, Bash K, et al. An overview of systematic reviews on the public health consequences of social isolation and loneliness. Public Health. Nov 2017;152:157-171.
  23. Courtin E, Knapp M. Social isolation, loneliness and health in old age: a scoping review. Health Soc Care Community. May 2017;25(3):799-812.
  24. Brown EG, Gallagher S, Creaven AM. Loneliness and acute stress reactivity: A systematic review of psychophysiological studies. Psychophysiology. May 2018;55(5):e13031.
  25. Dumbell R, Matveeva O, Oster H. Circadian Clocks, Stress, and Immunity. Front Endocrinol (Lausanne). 2016;7:37.
  26. Liyanarachchi K, Ross R, Debono M. Human studies on hypothalamo-pituitary-adrenal (HPA) axis. Best Pract Res Clin Endocrinol Metab. Oct 2017;31(5):459-473.
  27. Strohmaier S, Devore EE, Zhang Y, Schernhammer ES. A Review of Data of Findings on Night Shift Work and the Development of DM and CVD Events: a Synthesis of the Proposed Molecular Mechanisms. Curr Diab Rep. Oct 20 2018;18(12):132.
  28. De Nobrega AK, Lyons LC. Aging and the clock: Perspective from flies to humans. Eur J Neurosci. Sep 30 2018.
  29. Helfrich-Forster C. Interactions between psychosocial stress and the circadian endogenous clock. Psych J. Dec 2017;6(4):277-289.
  30. Ouakinin SRS, Barreira DP, Gois CJ. Depression and Obesity: Integrating the Role of Stress, Neuroendocrine Dysfunction and Inflammatory Pathways. Front Endocrinol (Lausanne). 2018;9:431.
  31. Bekhbat M, Rowson SA, Neigh GN. Checks and balances: The glucocorticoid receptor and NFkB in good times and bad. Front Neuroendocrinol. Jul 2017;46:15-31.
  32. Silverman MN, Sternberg EM. Glucocorticoid regulation of inflammation and its functional correlates: from HPA axis to glucocorticoid receptor dysfunction. Ann N Y Acad Sci. Jul 2012;1261:55-63.
  33. Nezi M, Mastorakos G, Mouslech Z. Corticotropin Releasing Hormone And The Immune/Inflammatory Response. [Updated 2015 Jul 30]. In: De Groot LJ, Chrousos G, Dungan K, et al., editors. Endotext [Internet]. South Dartmouth (MA):, Inc.; 2000-. Available from: In: De Groot LJ, Chrousos G, Dungan K, et al., eds. Endotext. South Dartmouth (MA):, Inc.; 2015.
  34. Meyer T, Wirtz PH. Mechanisms of Mitochondrial Redox Signaling in Psychosocial Stress-Responsive Systems: New Insights into an Old Story. Antioxid Redox Signal. Mar 20 2018;28(9):760-772.
  35. Rea K, Dinan TG, Cryan JF. The microbiome: A key regulator of stress and neuroinflammation. Neurobiol Stress. Oct 2016;4:23-33.
  36. Lerner A, Neidhofer S, Matthias T. The Gut Microbiome Feelings of the Brain: A Perspective for Non-Microbiologists. Microorganisms. Oct 12 2017;5(4).
  37. Farzi A, Frohlich EE, Holzer P. Gut Microbiota and the Neuroendocrine System. Neurotherapeutics. Jan 2018;15(1):5-22.
  38. Sudo N. Microbiome, HPA axis and production of endocrine hormones in the gut. Adv Exp Med Biol. 2014;817:177-194.
  39. van Bodegom M, Homberg JR, Henckens M. Modulation of the Hypothalamic-Pituitary-Adrenal Axis by Early Life Stress Exposure. Front Cell Neurosci. 2017;11:87.
  40. Reul JM, Collins A, Saliba RS, et al. Glucocorticoids, epigenetic control and stress resilience. Neurobiol Stress. Jan 2015;1:44-59.
  41. Constantinof A, Moisiadis VG, Matthews SG. Programming of stress pathways: A transgenerational perspective. J Steroid Biochem Mol Biol. Jun 2016;160:175-180.
  42. Dirven BCJ, Homberg JR, Kozicz T, Henckens M. Epigenetic programming of the neuroendocrine stress response by adult life stress. J Mol Endocrinol. Jul 2017;59(1):R11-r31.
  43. Jawaid A, Roszkowski M, Mansuy IM. Transgenerational Epigenetics of Traumatic Stress. Prog Mol Biol Transl Sci. 2018;158:273-298.
  44. Youssef NA, Lockwood L, Su S, Hao G, Rutten BPF. The Effects of Trauma, with or without PTSD, on the Transgenerational DNA Methylation Alterations in Human Offsprings. Brain Sci. May 8 2018;8(5).
  45. Epel ES, Lithgow GJ. Stress biology and aging mechanisms: toward understanding the deep connection between adaptation to stress and longevity. J Gerontol A Biol Sci Med Sci. Jun 2014;69 Suppl 1:S10-16.
  46. Peake JM, Markworth JF, Nosaka K, Raastad T, Wadley GD, Coffey VG. Modulating exercise-induced hormesis: Does less equal more? J Appl Physiol (1985). Aug 1 2015;119(3):172-189.
  47. Testa G, Biasi F, Poli G, Chiarpotto E. Calorie restriction and dietary restriction mimetics: a strategy for improving healthy aging and longevity. Curr Pharm Des. 2014;20(18):2950-2977.
  48. Ristow M, Schmeisser S. Extending life span by increasing oxidative stress. Free Radic Biol Med. Jul 15 2011;51(2):327-336.
  49. Lampert R, Tuit K, Hong KI, Donovan T, Lee F, Sinha R. Cumulative stress and autonomic dysregulation in a community sample. Stress. May 2016;19(3):269-279.
  50. Fioranelli M, Bottaccioli AG, Bottaccioli F, Bianchi M, Rovesti M, Roccia MG. Stress and Inflammation in Coronary Artery Disease: A Review Psychoneuroendocrineimmunology-Based. Front Immunol. 2018;9:2031.
  51. Kivimaki M, Kawachi I. Work Stress as a Risk Factor for Cardiovascular Disease. Curr Cardiol Rep. Sep 2015;17(9):630.
  52. Virtanen M, Kivimaki M. Long Working Hours and Risk of Cardiovascular Disease. Curr Cardiol Rep. Oct 1 2018;20(11):123.
  53. Nahrendorf M, Swirski FK. Lifestyle effects on hematopoiesis and atherosclerosis. Circ Res. Feb 27 2015;116(5):884-894.
  54. Gopalakrishnan P, Zaidi R, Sardar MR. Takotsubo cardiomyopathy: Pathophysiology and role of cardiac biomarkers in differential diagnosis. World J Cardiol. Sep 26 2017;9(9):723-730.
  55. Said SM, Saygili E, Rana OR, et al. Takotsubo Cardiomyopathy: What we have Learned in the Last 25 Years? (A Comparative Literature Review). Curr Cardiol Rev. 2016;12(4):297-303.
  56. Phillips C. Lifestyle Modulators of Neuroplasticity: How Physical Activity, Mental Engagement, and Diet Promote Cognitive Health during Aging. Neural Plast. 2017;2017:3589271.
  57. Calcia MA, Bonsall DR, Bloomfield PS, Selvaraj S, Barichello T, Howes OD. Stress and neuroinflammation: a systematic review of the effects of stress on microglia and the implications for mental illness. Psychopharmacology (Berl). May 2016;233(9):1637-1650.
  58. Piirainen S, Youssef A, Song C, et al. Psychosocial stress on neuroinflammation and cognitive dysfunctions in Alzheimer's disease: the emerging role for microglia? Neurosci Biobehav Rev. Jun 2017;77:148-164.
  59. Bisht K, Sharma K, Tremblay ME. Chronic stress as a risk factor for Alzheimer's disease: Roles of microglia-mediated synaptic remodeling, inflammation, and oxidative stress. Neurobiol Stress. Nov 2018;9:9-21.
  60. Kumar A, Pareek V, Faiq MA, et al. Regulatory role of NGFs in neurocognitive functions. Rev Neurosci. Jul 26 2017;28(6):649-673.
  61. Daskalakis NP, De Kloet ER, Yehuda R, Malaspina D, Kranz TM. Early Life Stress Effects on Glucocorticoid-BDNF Interplay in the Hippocampus. Front Mol Neurosci. 2015;8:68.
  62. Nowacka M, Obuchowicz E. BDNF and VEGF in the pathogenesis of stress-induced affective diseases: an insight from experimental studies. Pharmacol Rep. 2013;65(3):535-546.
  63. Makhathini KB, Abboussi O, Stein DJ, Mabandla MV, Daniels WMU. Repetitive stress leads to impaired cognitive function that is associated with DNA hypomethylation, reduced BDNF and a dysregulated HPA axis. Int J Dev Neurosci. Aug 2017;60:63-69.
  64. Eng JW, Kokolus KM, Reed CB, Hylander BL, Ma WW, Repasky EA. A nervous tumor microenvironment: the impact of adrenergic stress on cancer cells, immunosuppression, and immunotherapeutic response. Cancer Immunol Immunother. Nov 2014;63(11):1115-1128.
  65. Shin KJ, Lee YJ, Yang YR, et al. Molecular Mechanisms Underlying Psychological Stress and Cancer. Curr Pharm Des. 2016;22(16):2389-2402.
  66. Stults-Kolehmainen MA, Sinha R. The effects of stress on physical activity and exercise. Sports Med. Jan 2014;44(1):81-121.
  67. Mayo Clinic. Healthy Lifestyle: Stress Management. Available at Last updated 04/28/2016. Accessed 11/05/2018. 2016.
  68. Law E, Girgis A, Sylvie L, Levesque J, Pickett H. Telomeres and Stress: Promising Avenues for Research in Psycho-Oncology. Asia Pac J Oncol Nurs. Apr-Jun 2016;3(2):137-147.
  69. Pirl WF, Fann JR, Greer JA, et al. Recommendations for the implementation of distress screening programs in cancer centers: report from the American Psychosocial Oncology Society (APOS), Association of Oncology Social Work (AOSW), and Oncology Nursing Society (ONS) joint task force. Cancer. Oct 1 2014;120(19):2946-2954.
  70. Grassi L, Spiegel D, Riba M. Advancing psychosocial care in cancer patients. F1000Res. 2017;6:2083.
  71. Lacourt TE, Heijnen CJ. Mechanisms of Neurotoxic Symptoms as a Result of Breast Cancer and Its Treatment: Considerations on the Contribution of Stress, Inflammation, and Cellular Bioenergetics. Curr Breast Cancer Rep. 2017;9(2):70-81.
  72. Ferrucci L, Fabbri E. Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat Rev Cardiol. Sep 2018;15(9):505-522.
  73. Ayroldi E, Cannarile L, Adorisio S, Delfino DV, Riccardi C. Role of Endogenous Glucocorticoids in Cancer in the Elderly. Int J Mol Sci. Nov 27 2018;19(12).
  74. Del Pinto R, Ferri C. Inflammation-Accelerated Senescence and the Cardiovascular System: Mechanisms and Perspectives. Int J Mol Sci. Nov 22 2018;19(12).
  75. Masri S, Sassone-Corsi P. The emerging link between cancer, metabolism, and circadian rhythms. Nat Med. Dec 2018;24(12):1795-1803.
  76. Ans AH, Anjum I, Satija V, et al. Neurohormonal Regulation of Appetite and its Relationship with Stress: A Mini Literature Review. Cureus. Jul 23 2018;10(7):e3032.
  77. Joseph JJ, Golden SH. Cortisol dysregulation: the bidirectional link between stress, depression, and type 2 diabetes mellitus. Ann N Y Acad Sci. Mar 2017;1391(1):20-34.
  78. Kargi AY, Iacobellis G. Adipose tissue and adrenal glands: novel pathophysiological mechanisms and clinical applications. Int J Endocrinol. 2014;2014:614074.
  79. Champaneri S, Xu X, Carnethon MR, et al. Diurnal salivary cortisol is associated with body mass index and waist circumference: the Multiethnic Study of Atherosclerosis. Obesity (Silver Spring). Jan 2013;21(1):E56-63.
  80. Lemche E, Chaban OS, Lemche AV. Neuroendorine and Epigentic Mechanisms Subserving Autonomic Imbalance and HPA Dysfunction in the Metabolic Syndrome. Front Neurosci. 2016;10:142.
  81. Martocchia A, Stefanelli M, Falaschi GM, Toussan L, Ferri C, Falaschi P. Recent advances in the role of cortisol and metabolic syndrome in age-related degenerative diseases. Aging Clin Exp Res. Feb 2016;28(1):17-23.
  82. Diz-Chaves Y, Gil-Lozano M, Toba L, et al. Stressing diabetes? The hidden links between insulinotropic peptides and the HPA axis. J Endocrinol. Aug 2016;230(2):R77-94.
  83. Abdulateef DS, Mahwi TO. Assessment of hair cortisol in euthyroid, hypothyroid, and subclinical hypothyroid subjects. Endocrine. Sep 6 2018.
  84. Damian L, Ghiciuc CM, Dima-Cozma LC, et al. No definitive evidence for a connection between autoimmune thyroid diseases and stress in women. Neuro Endocrinol Lett. Jul 2016;37(3):155-162.
  85. Johnson EO, Kamilaris TC, Calogero AE, Konstandi M, Chrousos GP. Effects of short- and long-duration hypothyroidism on function of the rat hypothalamic-pituitary-adrenal axis. J Endocrinol Invest. Feb 2013;36(2):104-110.
  86. Johnson EO, Calogero AE, Konstandi M, Kamilaris TC, La Vignera S, Chrousos GP. Effects of short- and long-duration hypothyroidism on hypothalamic-pituitary-adrenal axis function in rats: in vitro and in situ studies. Endocrine. Dec 2012;42(3):684-693.
  87. Rosenberg SL, Miller GE, Brehm JM, Celedon JC. Stress and asthma: novel insights on genetic, epigenetic, and immunologic mechanisms. J Allergy Clin Immunol. Nov 2014;134(5):1009-1015.
  88. Lin TK, Zhong L, Santiago JL. Association between Stress and the HPA Axis in the Atopic Dermatitis. Int J Mol Sci. Oct 12 2017;18(10).
  89. Sharif K, Watad A, Coplan L, et al. The role of stress in the mosaic of autoimmunity: An overlooked association. Autoimmun Rev. Oct 2018;17(10):967-983.
  90. Romano GF, Tomassi S, Russell A, Mondelli V, Pariante CM. Fibromyalgia and chronic fatigue: the underlying biology and related theoretical issues. Adv Psychosom Med. 2015;34:61-77.
  91. Stover CM. Mechanisms of Stress-Mediated Modulation of Upper and Lower Respiratory Tract Infections. Adv Exp Med Biol. 2016;874:215-223.
  92. Sharma R, Biedenharn KR, Fedor JM, Agarwal A. Lifestyle factors and reproductive health: taking control of your fertility. Reprod Biol Endocrinol. Jul 16 2013;11:66.
  93. Pellissier S, Bonaz B. The Place of Stress and Emotions in the Irritable Bowel Syndrome. Vitam Horm. 2017;103:327-354.
  94. Maleki N, Becerra L, Borsook D. Migraine: maladaptive brain responses to stress. Headache. Oct 2012;52 Suppl 2(Suppl 2):102-106.
  95. Burke NN, Finn DP, McGuire BE, Roche M. Psychological stress in early life as a predisposing factor for the development of chronic pain: Clinical and preclinical evidence and neurobiological mechanisms. J Neurosci Res. Jun 2017;95(6):1257-1270.
  96. Buscemi V, Chang WJ, Liston MB, McAuley JH, Schabrun S. The role of psychosocial stress in the development of chronic musculoskeletal pain disorders: protocol for a systematic review and meta-analysis. Syst Rev. Nov 3 2017;6(1):224.
  97. Brotto L, Atallah S, Johnson-Agbakwu C, et al. Psychological and Interpersonal Dimensions of Sexual Function and Dysfunction. J Sex Med. Apr 2016;13(4):538-571.
  98. Turpeinen U, Hamalainen E. Determination of cortisol in serum, saliva and urine. Best Pract Res Clin Endocrinol Metab. Dec 2013;27(6):795-801.
  99. Wosu AC, Valdimarsdottir U, Shields AE, Williams DR, Williams MA. Correlates of cortisol in human hair: implications for epidemiologic studies on health effects of chronic stress. Ann Epidemiol. Dec 2013;23(12):797-811.e792.
  100. Kim LU, D'Orsogna MR, Chou T. Onset, timing, and exposure therapy of stress disorders: mechanistic insight from a mathematical model of oscillating neuroendocrine dynamics. Biol Direct. 2016;11(1):13.
  101. Inder WJ, Dimeski G, Russell A. Measurement of salivary cortisol in 2012 - laboratory techniques and clinical indications. Clin Endocrinol (Oxf). Nov 2012;77(5):645-651.
  102. Golden SH, Wand GS, Malhotra S, Kamel I, Horton K. Reliability of hypothalamic-pituitary-adrenal axis assessment methods for use in population-based studies. Eur J Epidemiol. Jul 2011;26(7):511-525.
  103. Adam EK, Quinn ME, Tavernier R, McQuillan MT, Dahlke KA, Gilbert KE. Diurnal cortisol slopes and mental and physical health outcomes: A systematic review and meta-analysis. Psychoneuroendocrinology. Sep 2017;83:25-41.
  104. Miller R, Stalder T, Jarczok M, et al. The CIRCORT database: Reference ranges and seasonal changes in diurnal salivary cortisol derived from a meta-dataset comprised of 15 field studies. Psychoneuroendocrinology. Nov 2016;73:16-23.
  105. Wright KD, Hickman R, Laudenslager ML. Hair Cortisol Analysis: A Promising Biomarker of HPA Activation in Older Adults. Gerontologist. Jun 2015;55 Suppl 1(Suppl 1):S140-145.
  106. Wester VL, van Rossum EF. Clinical applications of cortisol measurements in hair. Eur J Endocrinol. Oct 2015;173(4):M1-10.
  107. Silverman MN, Heim CM, Nater UM, Marques AH, Sternberg EM. Neuroendocrine and immune contributors to fatigue. Pm r. May 2010;2(5):338-346.
  108. Keremi B, Beck A, Fabian TK, et al. Stress and Salivary Glands. Curr Pharm Des. Oct 30 2017;23(27):4057-4065.
  109. Nater UM, Rohleder N. Salivary alpha-amylase as a non-invasive biomarker for the sympathetic nervous system: current state of research. Psychoneuroendocrinology. May 2009;34(4):486-496.
  110. Schumacher S, Kirschbaum C, Fydrich T, Strohle A. Is salivary alpha-amylase an indicator of autonomic nervous system dysregulations in mental disorders?--a review of preliminary findings and the interactions with cortisol. Psychoneuroendocrinology. Jun 2013;38(6):729-743.
  111. Cozma S, Dima-Cozma LC, Ghiciuc CM, Pasquali V, Saponaro A, Patacchioli FR. Salivary cortisol and alpha-amylase: subclinical indicators of stress as cardiometabolic risk. Braz J Med Biol Res. Feb 6 2017;50(2):e5577.
  112. Laufer S, Engel S, Knaevelsrud C, Schumacher S. Cortisol and alpha-amylase assessment in psychotherapeutic intervention studies: A systematic review. Neurosci Biobehav Rev. Dec 2018;95:235-262.
  113. Paszynska E, Dmitrzak-Weglarz M, Tyszkiewicz-Nwafor M, Slopien A. Salivary alpha-amylase, secretory IgA and free cortisol as neurobiological components of the stress response in the acute phase of anorexia nervosa. World J Biol Psychiatry. Jun 2016;17(4):266-273.
  114. Alaki SM, Safi A, Ouda S, Nadhreen A. Comparing Dental Stress in New Child Patients and Returning Patients Using Salivary Cortisol, Immunoglobulin-A and Alpha- Amylase. J Clin Pediatr Dent. 2017;41(6):462-466.
  115. Watanabe K, Shirakawa T. Characteristics of Perceived Stress and Salivary Levels of Secretory Immunoglobulin A and Cortisol in Japanese Women With Premenstrual Syndrome. Nurs Midwifery Stud. Jun 2015;4(2):e24795.
  116. Engeland CG, Hugo FN, Hilgert JB, et al. Psychological distress and salivary secretory immunity. Brain Behav Immun. Feb 2016;52:11-17.
  117. Romero-Martinez A, Moya-Albiol L. Stress-Induced Endocrine and Immune Dysfunctions in Caregivers of People with Eating Disorders. Int J Environ Res Public Health. Dec 13 2017;14(12).
  118. Strugnell RA, Wijburg OL. The role of secretory antibodies in infection immunity. Nat Rev Microbiol. Sep 2010;8(9):656-667.
  119. Obayashi K. Salivary mental stress proteins. Clin Chim Acta. Oct 21 2013;425:196-201.
  120. Strahler J, Skoluda N, Kappert MB, Nater UM. Simultaneous measurement of salivary cortisol and alpha-amylase: Application and recommendations. Neurosci Biobehav Rev. Dec 2017;83:657-677.
  121. Lennartsson AK, Theorell T, Rockwood AL, Kushnir MM, Jonsdottir IH. Perceived stress at work is associated with lower levels of DHEA-S. PLoS One. 2013;8(8):e72460.
  122. Mannic T, Viguie J, Rossier MF. In vivo and in vitro evidences of dehydroepiandrosterone protective role on the cardiovascular system. Int J Endocrinol Metab. Apr 2015;13(2):e24660.
  123. Samaras N, Samaras D, Frangos E, Forster A, Philippe J. A review of age-related dehydroepiandrosterone decline and its association with well-known geriatric syndromes: is treatment beneficial? Rejuvenation Res. Aug 2013;16(4):285-294.
  124. Shaffer F, Ginsberg JP. An Overview of Heart Rate Variability Metrics and Norms. Front Public Health. 2017;5:258.
  125. Kim HG, Cheon EJ, Bai DS, Lee YH, Koo BH. Stress and Heart Rate Variability: A Meta-Analysis and Review of the Literature. Psychiatry Investig. Mar 2018;15(3):235-245.
  126. Siegrist J, Li J. Work Stress and Altered Biomarkers: A Synthesis of Findings Based on the Effort-Reward Imbalance Model. Int J Environ Res Public Health. Nov 10 2017;14(11).
  127. Balzarotti S, Biassoni F, Colombo B, Ciceri MR. Cardiac vagal control as a marker of emotion regulation in healthy adults: A review. Biol Psychol. Dec 2017;130:54-66.
  128. Perez-Quilis C, Kingsley JD, Malkani K, Cervellin G, Lippi G, Sanchis-Gomar F. Modulation of Heart Rate by Acute or Chronic Aerobic Exercise. Potential Effects on Blood Pressure Control. Curr Pharm Des. 2017;23(31):4650-4657.
  129. Heckenberg RA, Eddy P, Kent S, Wright BJ. Do workplace-based mindfulness meditation programs improve physiological indices of stress? A systematic review and meta-analysis. J Psychosom Res. Nov 2018;114:62-71.
  130. Carnevali L, Koenig J, Sgoifo A, Ottaviani C. Autonomic and Brain Morphological Predictors of Stress Resilience. Front Neurosci. 2018;12:228.
  131. Cadegiani FA, Kater CE. Adrenal fatigue does not exist: a systematic review. BMC Endocr Disord. Aug 24 2016;16(1):48.
  132. Powell DJ, Liossi C, Moss-Morris R, Schlotz W. Unstimulated cortisol secretory activity in everyday life and its relationship with fatigue and chronic fatigue syndrome: a systematic review and subset meta-analysis. Psychoneuroendocrinology. Nov 2013;38(11):2405-2422.
  133. Munir S, Waseem M. Addison Disease. StatPearls. Treasure Island (FL): StatPearls Publishing LLC.; 2018.
  134. Koen N, Stein DJ. Pharmacotherapy of anxiety disorders: a critical review. Dialogues Clin Neurosci. 2011;13(4):423-437.
  135. Rougemont-Bucking A, Gamma F, Panksepp J. Use of tramadol in psychiatric care: A comprehensive review and report of two cases. Swiss Med Wkly. 2017;147:w14428.
  136. Santarsieri D, Schwartz TL. Antidepressant efficacy and side-effect burden: a quick guide for clinicians. Drugs Context. 2015;4:212290.
  137. Kirilly E, Gonda X, Bagdy G. [Antidepressants, stressors and the serotonin 1A receptor]. Neuropsychopharmacol Hung. Jun 2015;17(2):81-89.
  138. Gupta D, Radhakrishnan M, Bhatt S, Kurhe Y. Role of Hypothalamic-pituitary-adrenal-axis in Affective Disorders: Anti-depressant and Anxiolytic Activity of Partial 5-HT1A Agonist in Adrenalectomised Rats. Indian J Psychol Med. Jul 2013;35(3):290-298.
  139. Mayo Clinic. Buspirone (Oral Route): Side Effects. Available at Last updated 10/1/2018. Accessed 12/27/2018. 2018.
  140. Bossini L, Coluccia A, Casolaro I, et al. Off-Label Trazodone Prescription: Evidence, Benefits and Risks. Curr Pharm Des. 2015;21(23):3343-3351.
  141. Khouzam HR. A review of trazodone use in psychiatric and medical conditions. Postgrad Med. Jan 2017;129(1):140-148.
  142. Steenen SA, van Wijk AJ, van der Heijden GJ, van Westrhenen R, de Lange J, de Jongh A. Propranolol for the treatment of anxiety disorders: Systematic review and meta-analysis. J Psychopharmacol. Feb 2016;30(2):128-139.
  143. Mayo Clinic. Beta Blockers. Available at Last updates 4/6/2018. Accessed 12/22/18. 2018.
  144. Akbar S, Alorainy MS. The current status of beta blockers' use in the management of hypertension. Saudi Med J. Nov 2014;35(11):1307-1317.
  145. Dudek D, Jaeschke R, Styczen K, Pilecki M. Depression and anxiety in the practice of cardiology. Kardiol Pol. 2013;71(8):781-786.
  146. Celano CM, Daunis DJ, Lokko HN, Campbell KA, Huffman JC. Anxiety Disorders and Cardiovascular Disease. Curr Psychiatry Rep. Nov 2016;18(11):101.
  147. Dell'Osso B, Albert U, Atti AR, et al. Bridging the gap between education and appropriate use of benzodiazepines in psychiatric clinical practice. Neuropsychiatr Dis Treat. 2015;11:1885-1909.
  148. Ramirez K, Niraula A, Sheridan JF. GABAergic modulation with classical benzodiazepines prevent stress-induced neuro-immune dysregulation and behavioral alterations. Brain Behav Immun. Jan 2016;51:154-168.
  149. Jung S, Spence MM, Escasa NM, Lee EA, Hui RL, Gibbs NE. The Risk of Pneumonia in Older Adults Using Nonbenzodiazepine Hypnotics. J Manag Care Spec Pharm. Aug 2016;22(8):932-938.
  150. Kuntz J, Kouch L, Christian D, Peterson PL, Gruss I. Barriers and Facilitators to the Deprescribing of Nonbenzodiazepine Sedative Medications Among Older Adults. Perm J. 2018;22.
  151. Wilt TJ, MacDonald R, Brasure M, et al. Pharmacologic Treatment of Insomnia Disorder: An Evidence Report for a Clinical Practice Guideline by the American College of Physicians. Ann Intern Med. Jul 19 2016;165(2):103-112.
  152. Cleare AJ, Miell J, Heap E, et al. Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy. J Clin Endocrinol Metab. Aug 2001;86(8):3545-3554.
  153. Blockmans D, Persoons P, Van Houdenhove B, Lejeune M, Bobbaers H. Combination therapy with hydrocortisone and fludrocortisone does not improve symptoms in chronic fatigue syndrome: a randomized, placebo-controlled, double-blind, crossover study. Am J Med. Jun 15 2003;114(9):736-741.
  154. McKenzie R, O'Fallon A, Dale J, et al. Low-dose hydrocortisone for treatment of chronic fatigue syndrome: a randomized controlled trial. Jama. Sep 23-30 1998;280(12):1061-1066.
  155. Hofmann SG, Asnaani A, Vonk IJ, Sawyer AT, Fang A. The Efficacy of Cognitive Behavioral Therapy: A Review of Meta-analyses. Cognit Ther Res. Oct 1 2012;36(5):427-440.
  156. Lindsater E, Axelsson E, Salomonsson S, et al. Internet-Based Cognitive Behavioral Therapy for Chronic Stress: A Randomized Controlled Trial. Psychother Psychosom. 2018;87(5):296-305.
  157. Anclair M, Lappalainen R, Muotka J, Hiltunen AJ. Cognitive behavioural therapy and mindfulness for stress and burnout: a waiting list controlled pilot study comparing treatments for parents of children with chronic conditions. Scand J Caring Sci. Mar 2018;32(1):389-396.
  158. Carpenter JK, Andrews LA, Witcraft SM, Powers MB, Smits JAJ, Hofmann SG. Cognitive behavioral therapy for anxiety and related disorders: A meta-analysis of randomized placebo-controlled trials. Depress Anxiety. Jun 2018;35(6):502-514.
  159. Baker N. Using Cognitive Behavior Therapy and Mindfulness Techniques in the Management of Chronic Pain in Primary Care. Prim Care. Jun 2016;43(2):203-216.
  160. Eller-Smith OC, Nicol AL, Christianson JA. Potential Mechanisms Underlying Centralized Pain and Emerging Therapeutic Interventions. Front Cell Neurosci. 2018;12:35.
  161. Karlsson B, Burell G, Anderberg UM, Svardsudd K. Cognitive behaviour therapy in women with fibromyalgia: A randomized clinical trial. Scand J Pain. Oct 1 2015;9(1):11-21.
  162. Schiller H, Soderstrom M, Lekander M, Rajaleid K, Kecklund G. A randomized controlled intervention of workplace-based group cognitive behavioral therapy for insomnia. Int Arch Occup Environ Health. May 2018;91(4):413-424.
  163. Bishop JR, Lee AM, Mills LJ, et al. Methylation of FKBP5 and SLC6A4 in Relation to Treatment Response to Mindfulness Based Stress Reduction for Posttraumatic Stress Disorder. Front Psychiatry. 2018;9:418.
  164. Bergen-Cico D, Possemato K, Pigeon W. Reductions in cortisol associated with primary care brief mindfulness program for veterans with PTSD. Med Care. Dec 2014;52(12 Suppl 5):S25-31.
  165. Pascoe MC, Thompson DR, Jenkins ZM, Ski CF. Mindfulness mediates the physiological markers of stress: Systematic review and meta-analysis. J Psychiatr Res. Dec 2017;95:156-178.
  166. Levine GN, Lange RA, Bairey-Merz CN, et al. Meditation and Cardiovascular Risk Reduction: A Scientific Statement From the American Heart Association. J Am Heart Assoc. Sep 28 2017;6(10).
  167. Guillaumie L, Boiral O, Champagne J. A mixed-methods systematic review of the effects of mindfulness on nurses. J Adv Nurs. May 2017;73(5):1017-1034.
  168. Lamothe M, Rondeau E, Malboeuf-Hurtubise C, Duval M, Sultan S. Outcomes of MBSR or MBSR-based interventions in health care providers: A systematic review with a focus on empathy and emotional competencies. Complement Ther Med. Feb 2016;24:19-28.
  169. Janssen M, Heerkens Y, Kuijer W, van der Heijden B, Engels J. Effects of Mindfulness-Based Stress Reduction on employees' mental health: A systematic review. PLoS One. 2018;13(1):e0191332.
  170. Ravalier JM, Wegrzynek P, Lawton S. Systematic review: complementary therapies and employee well-being. Occup Med (Lond). Aug 2016;66(6):428-436.
  171. Daubenmier J, Kristeller J, Hecht FM, et al. Mindfulness Intervention for Stress Eating to Reduce Cortisol and Abdominal Fat among Overweight and Obese Women: An Exploratory Randomized Controlled Study. J Obes. 2011;2011:651936.
  172. Fish J, Brimson J, Lynch S. Mindfulness Interventions Delivered by Technology Without Facilitator Involvement: What Research Exists and What Are the Clinical Outcomes? Mindfulness (N Y). 2016;7(5):1011-1023.
  173. Carolan S, Harris PR, Cavanagh K. Improving Employee Well-Being and Effectiveness: Systematic Review and Meta-Analysis of Web-Based Psychological Interventions Delivered in the Workplace. J Med Internet Res. Jul 26 2017;19(7):e271.
  174. Heber E, Ebert DD, Lehr D, et al. The Benefit of Web- and Computer-Based Interventions for Stress: A Systematic Review and Meta-Analysis. J Med Internet Res. Feb 17 2017;19(2):e32.
  175. Huffman DM, Schafer MJ, LeBrasseur NK. Energetic interventions for healthspan and resiliency with aging. Exp Gerontol. Dec 15 2016;86:73-83.
  176. Stubbs B, Vancampfort D, Rosenbaum S, et al. An examination of the anxiolytic effects of exercise for people with anxiety and stress-related disorders: A meta-analysis. Psychiatry Res. Mar 2017;249:102-108.
  177. Ortega E. The "bioregulatory effect of exercise" on the innate/inflammatory responses. J Physiol Biochem. Jun 2016;72(2):361-369.
  178. Kline CE. The bidirectional relationship between exercise and sleep: Implications for exercise adherence and sleep improvement. Am J Lifestyle Med. Nov-Dec 2014;8(6):375-379.
  179. Asmundson GJ, Fetzner MG, Deboer LB, Powers MB, Otto MW, Smits JA. Let's get physical: a contemporary review of the anxiolytic effects of exercise for anxiety and its disorders. Depress Anxiety. Apr 2013;30(4):362-373.
  180. Mikkelsen K, Stojanovska L, Polenakovic M, Bosevski M, Apostolopoulos V. Exercise and mental health. Maturitas. Dec 2017;106:48-56.
  181. Huang CJ, Webb HE, Zourdos MC, Acevedo EO. Cardiovascular reactivity, stress, and physical activity. Front Physiol. Nov 7 2013;4:314.
  182. Bernard P, Dore I, Romain AJ, Hains-Monfette G, Kingsbury C, Sabiston C. Dose response association of objective physical activity with mental health in a representative national sample of adults: A cross-sectional study. PLoS One. 2018;13(10):e0204682.
  183. Gordon BR, McDowell CP, Lyons M, Herring MP. The Effects of Resistance Exercise Training on Anxiety: A Meta-Analysis and Meta-Regression Analysis of Randomized Controlled Trials. Sports Med. Dec 2017;47(12):2521-2532.
  184. Kovacevic A, Mavros Y, Heisz JJ, Fiatarone Singh MA. The effect of resistance exercise on sleep: A systematic review of randomized controlled trials. Sleep Med Rev. Jun 2018;39:52-68.
  185. Leow S, Jackson B, Alderson JA, Guelfi KJ, Dimmock JA. A Role for Exercise in Attenuating Unhealthy Food Consumption in Response to Stress. Nutrients. Feb 6 2018;10(2).
  186. van Praag H, Fleshner M, Schwartz MW, Mattson MP. Exercise, energy intake, glucose homeostasis, and the brain. J Neurosci. Nov 12 2014;34(46):15139-15149.
  187. Wasfy MM, Baggish AL. Exercise Dose in Clinical Practice. Circulation. Jun 7 2016;133(23):2297-2313.
  188. Mitchell M, White L, Lau E, Leahey T, Adams MA, Faulkner G. Evaluating the Carrot Rewards App, a Population-Level Incentive-Based Intervention Promoting Step Counts Across Two Canadian Provinces: Quasi-Experimental Study. JMIR Mhealth Uhealth. Sep 20 2018;6(9):e178.
  189. Kramer JN, Tinschert P, Scholz U, Fleisch E, Kowatsch T. A Cluster-Randomized Trial on Small Incentives to Promote Physical Activity. Am J Prev Med. Dec 13 2018.
  190. Yuenyongchaiwat K. Effects of 10,000 steps a day on physical and mental health in overweight participants in a community setting: a preliminary study. Braz J Phys Ther. Jul-Aug 2016;20(4):367-373.
  191. Liau AK, Neihart M, Teo CT, Goh LS, Chew P. A Quasi-Experimental Study of a Fitbit-Based Self-Regulation Intervention to Improve Physical Activity, Well-Being, and Mental Health. Cyberpsychol Behav Soc Netw. Nov 2018;21(11):727-734.
  192. Friedman E, Krause-Parello CA. Companion animals and human health: benefits, challenges, and the road ahead for human-animal interaction. Rev Sci Tech. Apr 2018;37(1):71-82.
  193. Ogechi I, Snook K, Davis BM, Hansen AR, Liu F, Zhang J. Pet Ownership and the Risk of Dying from Cardiovascular Disease Among Adults Without Major Chronic Medical Conditions. High Blood Press Cardiovasc Prev. Sep 2016;23(3):245-253.
  194. Qureshi AI, Memon MZ, Vazquez G, Suri MF. Cat ownership and the Risk of Fatal Cardiovascular Diseases. Results from the Second National Health and Nutrition Examination Study Mortality Follow-up Study. J Vasc Interv Neurol. Jan 2009;2(1):132-135.
  195. Arhant-Sudhir K, Arhant-Sudhir R, Sudhir K. Pet ownership and cardiovascular risk reduction: supporting evidence, conflicting data and underlying mechanisms. Clin Exp Pharmacol Physiol. Nov 2011;38(11):734-738.
  196. Virues-Ortega J, Buela-Casal G. Psychophysiological effects of human-animal interaction: theoretical issues and long-term interaction effects. J Nerv Ment Dis. Jan 2006;194(1):52-57.
  197. Pickering TG. Men are from Mars, women are from Venus: stress, pets, and oxytocin. J Clin Hypertens (Greenwich). Jan-Feb 2003;5(1):86-88.
  198. Lundqvist M, Carlsson P, Sjodahl R, Theodorsson E, Levin LA. Patient benefit of dog-assisted interventions in health care: a systematic review. BMC Complement Altern Med. Jul 10 2017;17(1):358.
  199. Polheber JP, Matchock RL. The presence of a dog attenuates cortisol and heart rate in the Trier Social Stress Test compared to human friends. J Behav Med. Oct 2014;37(5):860-867.
  200. Allen K, Blascovich J, Mendes WB. Cardiovascular reactivity and the presence of pets, friends, and spouses: the truth about cats and dogs. Psychosom Med. Sep-Oct 2002;64(5):727-739.
  201. Oyola MG, Handa RJ. Hypothalamic-pituitary-adrenal and hypothalamic-pituitary-gonadal axes: sex differences in regulation of stress responsivity. Stress. Sep 2017;20(5):476-494.
  202. Toufexis D, Rivarola MA, Lara H, Viau V. Stress and the reproductive axis. J Neuroendocrinol. Sep 2014;26(9):573-586.
  203. Stephens MA, Mahon PB, McCaul ME, Wand GS. Hypothalamic-pituitary-adrenal axis response to acute psychosocial stress: Effects of biological sex and circulating sex hormones. Psychoneuroendocrinology. Apr 2016;66:47-55.
  204. Wirth MM. Beyond the HPA Axis: Progesterone-Derived Neuroactive Steroids in Human Stress and Emotion. Front Endocrinol (Lausanne). 2011;2:19.
  205. Ziomkiewicz A, Pawlowski B, Ellison PT, Lipson SF, Thune I, Jasienska G. Higher luteal progesterone is associated with low levels of premenstrual aggressive behavior and fatigue. Biol Psychol. Dec 2012;91(3):376-382.
  206. Patacchioli FR, Ghiciuc CM, Bernardi M, et al. Salivary alpha-amylase and cortisol after exercise in menopause: influence of long-term HRT. Climacteric. 2015;18(4):528-535.
  207. Herrera AY, Hodis HN, Mack WJ, Mather M. Estradiol Therapy After Menopause Mitigates Effects of Stress on Cortisol and Working Memory. J Clin Endocrinol Metab. Dec 1 2017;102(12):4457-4466.
  208. Steffen AM, Thompson LW, Gallagher-Thompson D, Koin D. Physical and psychosocial correlates of hormone replacement therapy with chronically stressed postmenopausal women. J Aging Health. Feb 1999;11(1):3-26.
  209. Prior JC. Progesterone for Symptomatic Perimenopause Treatment - Progesterone politics, physiology and potential for perimenopause. Facts Views Vis Obgyn. 2011;3(2):109-120.
  210. Leeangkoonsathian E, Pantasri T, Chaovisitseree S, Morakot N. The effect of different progestogens on sleep in postmenopausal women: a randomized trial. Gynecol Endocrinol. Dec 2017;33(12):933-936.
  211. Espinosa-Garcia C, Sayeed I, Yousuf S, et al. Stress primes microglial polarization after global ischemia: Therapeutic potential of progesterone. Brain Behav Immun. Nov 2017;66:177-192.
  212. Tomiyama AJ, Dallman MF, Epel ES. Comfort food is comforting to those most stressed: evidence of the chronic stress response network in high stress women. Psychoneuroendocrinology. Nov 2011;36(10):1513-1519.
  213. Jaremka LM, Belury MA, Andridge RR, et al. Interpersonal stressors predict ghrelin and leptin levels in women. Psychoneuroendocrinology. Oct 2014;48:178-188.
  214. Yau YH, Potenza MN. Stress and eating behaviors. Minerva Endocrinol. Sep 2013;38(3):255-267.
  215. Tryon MS, DeCant R, Laugero KD. Having your cake and eating it too: a habit of comfort food may link chronic social stress exposure and acute stress-induced cortisol hyporesponsiveness. Physiol Behav. Apr 10 2013;114-115:32-37.
  216. Tryon MS, Stanhope KL, Epel ES, et al. Excessive Sugar Consumption May Be a Difficult Habit to Break: A View From the Brain and Body. J Clin Endocrinol Metab. Jun 2015;100(6):2239-2247.
  217. Errisuriz VL, Pasch KE, Perry CL. Perceived stress and dietary choices: The moderating role of stress management. Eat Behav. Aug 2016;22:211-216.
  218. Aschbacher K, Kornfeld S, Picard M, et al. Chronic stress increases vulnerability to diet-related abdominal fat, oxidative stress, and metabolic risk. Psychoneuroendocrinology. Aug 2014;46:14-22.
  219. Wang J, Um P, Dickerman BA, Liu J. Zinc, Magnesium, Selenium and Depression: A Review of the Evidence, Potential Mechanisms and Implications. Nutrients. May 9 2018;10(5).
  220. Singh K. Nutrient and Stress Management. J Nutr Food Sci. 2016;6(4).
  221. Conner TS, Brookie KL, Carr AC, Mainvil LA, Vissers MC. Let them eat fruit! The effect of fruit and vegetable consumption on psychological well-being in young adults: A randomized controlled trial. PLoS One. 2017;12(2):e0171206.
  222. Garcia-Prieto MD, Tebar FJ, Nicolas F, Larque E, Zamora S, Garaulet M. Cortisol secretary pattern and glucocorticoid feedback sensitivity in women from a Mediterranean area: relationship with anthropometric characteristics, dietary intake and plasma fatty acid profile. Clin Endocrinol (Oxf). Feb 2007;66(2):185-191.
  223. Carvalho KMB, Ronca DB, Michels N, et al. Does the Mediterranean Diet Protect against Stress-Induced Inflammatory Activation in European Adolescents? The HELENA Study. Nutrients. Nov 15 2018;10(11).
  224. Martucci M, Ostan R, Biondi F, et al. Mediterranean diet and inflammaging within the hormesis paradigm. Nutr Rev. Jun 1 2017;75(6):442-455.
  225. Chaplin K, Smith AP. Breakfast and snacks: associations with cognitive failures, minor injuries, accidents and stress. Nutrients. May 2011;3(5):515-528.
  226. Witbracht M, Keim NL, Forester S, Widaman A, Laugero K. Female breakfast skippers display a disrupted cortisol rhythm and elevated blood pressure. Physiol Behav. Mar 1 2015;140:215-221.
  227. Nehlig A. Effects of coffee/caffeine on brain health and disease: What should I tell my patients? Pract Neurol. Apr 2016;16(2):89-95.
  228. Yang A, Palmer AA, de Wit H. Genetics of caffeine consumption and responses to caffeine. Psychopharmacology (Berl). Aug 2010;211(3):245-257.
  229. al'Absi M, & Lovallo, W. R. . Caffeine's effects on the human stress axis. In A. Nehlig (Ed.), Nutrition, brain, and behavior. Coffee, tea, chocolate, and the brain (pp. 113-131). Boca Raton, FL, US: CRC Press. 2004.
  230. Lovallo WR, Whitsett TL, al'Absi M, Sung BH, Vincent AS, Wilson MF. Caffeine stimulation of cortisol secretion across the waking hours in relation to caffeine intake levels. Psychosom Med. Sep-Oct 2005;67(5):734-739.
  231. Lovallo WR, Farag NH, Vincent AS, Thomas TL, Wilson MF. Cortisol responses to mental stress, exercise, and meals following caffeine intake in men and women. Pharmacol Biochem Behav. Mar 2006;83(3):441-447.
  232. Gonzaga LA, Vanderlei LCM, Gomes RL, Valenti VE. Caffeine affects autonomic control of heart rate and blood pressure recovery after aerobic exercise in young adults: a crossover study. Sci Rep. Oct 26 2017;7(1):14091.
  233. Hamer M, Williams ED, Vuononvirta R, Gibson EL, Steptoe A. Association between coffee consumption and markers of inflammation and cardiovascular function during mental stress. J Hypertens. Nov 2006;24(11):2191-2197.
  234. Beaudoin MS, Graham TE. Methylxanthines and human health: epidemiological and experimental evidence. Handb Exp Pharmacol. 2011(200):509-548.
  235. Schrieks IC, Joosten MM, Klopping-Ketelaars WA, Witkamp RF, Hendriks HF. Moderate alcohol consumption after a mental stressor attenuates the endocrine stress response. Alcohol. Dec 2016;57:29-34.
  236. Kokavec A, Crowe SF. The effect of a moderate level of white wine consumption on the hypothalamic-pituitary-adrenal axis before and after a meal. Pharmacol Biochem Behav. Oct-Nov 2001;70(2-3):243-250.
  237. Cupic Z, Stanojevic A, Markovic VM, Kolar-Anic L, Terenius L, Vukojevic V. The HPA axis and ethanol: a synthesis of mathematical modelling and experimental observations. Addict Biol. Nov 2017;22(6):1486-1500.
  238. Rachdaoui N, Sarkar DK. Pathophysiology of the Effects of Alcohol Abuse on the Endocrine System. Alcohol Res. 2017;38(2):255-276.
  239. Blaine SK, Sinha R. Alcohol, stress, and glucocorticoids: From risk to dependence and relapse in alcohol use disorders. Neuropharmacology. Aug 1 2017;122:136-147.
  240. Hipson WE, Fisher DJ. The association between acute stress-related insomnia and alcohol use. Sleep Health. Sep 2016;2(3):246-252.
  241. Keyes KM, Hatzenbuehler ML, Grant BF, Hasin DS. Stress and alcohol: epidemiologic evidence. Alcohol Res. 2012;34(4):391-400.
  242. Leahy LG. Vitamin B Supplementation: What's the Right Choice for Your Patients? J Psychosoc Nurs Ment Health Serv. Jul 1 2017;55(7):7-11.
  243. Kennedy DO. B Vitamins and the Brain: Mechanisms, Dose and Efficacy--A Review. Nutrients. Jan 27 2016;8(2):68.
  244. Macpherson H, Rowsell R, Cox KH, et al. The Effects of Four-Week Multivitamin Supplementation on Mood in Healthy Older Women: A Randomized Controlled Trial. Evid Based Complement Alternat Med. 2016;2016:3092828.
  245. Macpherson H, Rowsell R, Cox KH, Scholey A, Pipingas A. Acute mood but not cognitive improvements following administration of a single multivitamin and mineral supplement in healthy women aged 50 and above: a randomised controlled trial. Age (Dordr). Jun 2015;37(3):9782.
  246. Pipingas A, Camfield DA, Stough C, et al. The effects of multivitamin supplementation on mood and general well-being in healthy young adults. A laboratory and at-home mobile phone assessment. Appetite. Oct 2013;69:123-136.
  247. Sarris J, Cox KH, Camfield DA, et al. Participant experiences from chronic administration of a multivitamin versus placebo on subjective health and wellbeing: a double-blind qualitative analysis of a randomised controlled trial. Nutr J. Dec 14 2012;11:110.
  248. Harris E, Kirk J, Rowsell R, et al. The effect of multivitamin supplementation on mood and stress in healthy older men. Hum Psychopharmacol. Dec 2011;26(8):560-567.
  249. Stough C, Scholey A, Lloyd J, Spong J, Myers S, Downey LA. The effect of 90 day administration of a high dose vitamin B-complex on work stress. Hum Psychopharmacol. Oct 2011;26(7):470-476.
  250. Long SJ, Benton D. Effects of vitamin and mineral supplementation on stress, mild psychiatric symptoms, and mood in nonclinical samples: a meta-analysis. Psychosom Med. Feb 2013;75(2):144-153.
  251. Camfield DA, Wetherell MA, Scholey AB, et al. The effects of multivitamin supplementation on diurnal cortisol secretion and perceived stress. Nutrients. Nov 11 2013;5(11):4429-4450.
  252. Li X, Huang WX, Lu JM, et al. Effects of a multivitamin/multimineral supplement on young males with physical overtraining: a placebo-controlled, randomized, double-blinded cross-over trial. Biomed Environ Sci. Jul 2013;26(7):599-604.
  253. Figueroa-Méndez R, Rivas-Arancibia S. Vitamin C in Health and Disease: Its Role in the Metabolism of Cells and Redox State in the Brain. Front Physiol. 2015;6:397.
  254. Kocot J, Luchowska-Kocot D, Kielczykowska M, Musik I, Kurzepa J. Does Vitamin C Influence Neurodegenerative Diseases and Psychiatric Disorders? Nutrients. Jun 27 2017;9(7).
  255. Han QQ, Shen TT, Wang F, Wu PF, Chen JG. Preventive and Therapeutic Potential of Vitamin C in Mental Disorders. Curr Med Sci. Feb 2018;38(1):1-10.
  256. Chambial S, Dwivedi S, Shukla KK, John PJ, Sharma P. Vitamin C in disease prevention and cure: an overview. Indian J Clin Biochem. Oct 2013;28(4):314-328.
  257. Gautam M, Agrawal M, Gautam M, Sharma P, Gautam AS, Gautam S. Role of antioxidants in generalised anxiety disorder and depression. Indian J Psychiatry. Jul 2012;54(3):244-247.
  258. de Oliveira IJ, de Souza VV, Motta V, Da-Silva SL. Effects of Oral Vitamin C Supplementation on Anxiety in Students: A Double-Blind, Randomized, Placebo-Controlled Trial. Pak J Biol Sci. Jan 2015;18(1):11-18.
  259. McCabe D, Lisy K, Lockwood C, Colbeck M. The impact of essential fatty acid, B vitamins, vitamin C, magnesium and zinc supplementation on stress levels in women: a systematic review. JBI Database System Rev Implement Rep. Feb 2017;15(2):402-453.
  260. Taylor AM, Holscher HD. A review of dietary and microbial connections to depression, anxiety, and stress. Nutr Neurosci. Jul 9 2018:1-14.
  261. Husted KS, Bouzinova EV. The importance of n-6/n-3 fatty acids ratio in the major depressive disorder. Medicina (Kaunas). 2016;52(3):139-147.
  262. Su KP, Matsuoka Y, Pae CU. Omega-3 Polyunsaturated Fatty Acids in Prevention of Mood and Anxiety Disorders. Clin Psychopharmacol Neurosci. Aug 31 2015;13(2):129-137.
  263. Thesing CS, Bot M, Milaneschi Y, Giltay EJ, Penninx B. Omega-3 polyunsaturated fatty acid levels and dysregulations in biological stress systems. Psychoneuroendocrinology. Nov 2018;97:206-215.
  264. Fernandes MF, Mutch DM, Leri F. The Relationship between Fatty Acids and Different Depression-Related Brain Regions, and Their Potential Role as Biomarkers of Response to Antidepressants. Nutrients. Mar 17 2017;9(3).
  265. Sauder KA, Skulas-Ray AC, Campbell TS, Johnson JA, Kris-Etherton PM, West SG. Effects of omega-3 fatty acid supplementation on heart rate variability at rest and during acute stress in adults with moderate hypertriglyceridemia. Psychosom Med. May 2013;75(4):382-389.
  266. Barbadoro P, Annino I, Ponzio E, et al. Fish oil supplementation reduces cortisol basal levels and perceived stress: a randomized, placebo-controlled trial in abstinent alcoholics. Mol Nutr Food Res. Jun 2013;57(6):1110-1114.
  267. Mocking RJ, Verburg HF, Westerink AM, et al. Fatty acid metabolism and its longitudinal relationship with the hypothalamic-pituitary-adrenal axis in major depression: Associations with prospective antidepressant response. Psychoneuroendocrinology. Sep 2015;59:1-13.
  268. Turkozu D, Sanlier N. L-theanine, unique amino acid of tea, and its metabolism, health effects, and safety. Crit Rev Food Sci Nutr. May 24 2017;57(8):1681-1687.
  269. Unno K, Tanida N, Ishii N, et al. Anti-stress effect of theanine on students during pharmacy practice: positive correlation among salivary alpha-amylase activity, trait anxiety and subjective stress. Pharmacol Biochem Behav. Oct 2013;111:128-135.
  270. White DJ, de Klerk S, Woods W, Gondalia S, Noonan C, Scholey AB. Anti-Stress, Behavioural and Magnetoencephalography Effects of an L-Theanine-Based Nutrient Drink: A Randomised, Double-Blind, Placebo-Controlled, Crossover Trial. Nutrients. Jan 19 2016;8(1).
  271. Giles GE, Mahoney CR, Brunye TT, Taylor HA, Kanarek RB. Caffeine and theanine exert opposite effects on attention under emotional arousal. Can J Physiol Pharmacol. Jan 2017;95(1):93-100.
  272. Cicero AF, Bove M, Colletti A, et al. Short-Term Impact of a Combined Nutraceutical on Cognitive Function, Perceived Stress and Depression in Young Elderly with Cognitive Impairment: A Pilot, Double-Blind, Randomized Clinical Trial. J Prev Alzheimers Dis. 2017;4(1):12-15.
  273. Kingsley M. Effects of phosphatidylserine supplementation on exercising humans. Sports Med. 2006;36(8):657-669.
  274. Hellhammer J, Vogt D, Franz N, Freitas U, Rutenberg D. A soy-based phosphatidylserine/ phosphatidic acid complex (PAS) normalizes the stress reactivity of hypothalamus-pituitary-adrenal-axis in chronically stressed male subjects: a randomized, placebo-controlled study. Lipids Health Dis. Jul 31 2014;13:121.
  275. Hellhammer J, Fries E, Buss C, et al. Effects of soy lecithin phosphatidic acid and phosphatidylserine complex (PAS) on the endocrine and psychological responses to mental stress. Stress. Jun 2004;7(2):119-126.
  276. Benton D, Donohoe RT, Sillance B, Nabb S. The influence of phosphatidylserine supplementation on mood and heart rate when faced with an acute stressor. Nutr Neurosci. 2001;4(3):169-178.
  277. Starks MA, Starks SL, Kingsley M, Purpura M, Jager R. The effects of phosphatidylserine on endocrine response to moderate intensity exercise. J Int Soc Sports Nutr. Jul 28 2008;5:11.
  278. Porter RJ, Gallagher P, Watson S, Young AH. Corticosteroid-serotonin interactions in depression: a review of the human evidence. Psychopharmacology (Berl). Apr 2004;173(1-2):1-17.
  279. Michels N, Clarke G, Olavarria-Ramirez L, et al. Psychosocial stress and inflammation driving tryptophan breakdown in children and adolescents: A cross-sectional analysis of two cohorts. Psychoneuroendocrinology. Aug 2018;94:104-111.
  280. Hood SD, Hince DA, Robinson H, Cirillo M, Christmas D, Kaye JM. Serotonin regulation of the human stress response. Psychoneuroendocrinology. Oct 2006;31(9):1087-1097.
  281. Capello AE, Markus CR. Effect of sub chronic tryptophan supplementation on stress-induced cortisol and appetite in subjects differing in 5-HTTLPR genotype and trait neuroticism. Psychoneuroendocrinology. Jul 2014;45:96-107.
  282. Cerit H, Jans LA, Van der Does W. The effect of tryptophan on the cortisol response to social stress is modulated by the 5-HTTLPR genotype. Psychoneuroendocrinology. Feb 2013;38(2):201-208.
  283. Markus CR, Firk C. Differential effects of tri-allelic 5-HTTLPR polymorphisms in healthy subjects on mood and stress performance after tryptophan challenge. Neuropsychopharmacology. Dec 2009;34(13):2667-2674.
  284. Firk C, Markus CR. Mood and cortisol responses following tryptophan-rich hydrolyzed protein and acute stress in healthy subjects with high and low cognitive reactivity to depression. Clin Nutr. Jun 2009;28(3):266-271.
  285. Mohanty DP, Mohapatra S, Misra S, Sahu PS. Milk derived bioactive peptides and their impact on human health - A review. Saudi J Biol Sci. Sep 2016;23(5):577-583.
  286. Layman DK, Lonnerdal B, Fernstrom JD. Applications for alpha-lactalbumin in human nutrition. Nutr Rev. Jun 1 2018;76(6):444-460.
  287. Yayeh T, Leem YH, Kim KM, et al. Administration of Alphas1-Casein Hydrolysate Increases Sleep and Modulates GABAA Receptor Subunit Expression. Biomol Ther (Seoul). May 1 2018;26(3):268-273.
  288. Dela Pena IJ, Kim HJ, de la Pena JB, et al. A tryptic hydrolysate from bovine milk alphas1-casein enhances pentobarbital-induced sleep in mice via the GABAA receptor. Behav Brain Res. Oct 15 2016;313:184-190.
  289. Guesdon B, Messaoudi M, Lefranc-Millot C, Fromentin G, Tome D, Even PC. A tryptic hydrolysate from bovine milk alphaS1-casein improves sleep in rats subjected to chronic mild stress. Peptides. Jun 2006;27(6):1476-1482.
  290. Kim JH, Desor D, Kim YT, et al. Efficacy of alphas1-casein hydrolysate on stress-related symptoms in women. Eur J Clin Nutr. Apr 2007;61(4):536-541.
  291. Messaoudi M, Lefranc-Millot C, Desor D, Demagny B, Bourdon L. Effects of a tryptic hydrolysate from bovine milk alphaS1-casein on hemodynamic responses in healthy human volunteers facing successive mental and physical stress situations. Eur J Nutr. Mar 2005;44(2):128-132.
  292. Misra S, Mohanty D. Psychobiotics: A new approach for treating mental illness? Crit Rev Food Sci Nutr. Nov 30 2017:1-7.
  293. Takada M, Nishida K, Kataoka-Kato A, et al. Probiotic Lactobacillus casei strain Shirota relieves stress-associated symptoms by modulating the gut-brain interaction in human and animal models. Neurogastroenterol Motil. Jul 2016;28(7):1027-1036.
  294. Kato-Kataoka A, Nishida K, Takada M, et al. Fermented milk containing Lactobacillus casei strain Shirota prevents the onset of physical symptoms in medical students under academic examination stress. Benef Microbes. 2016;7(2):153-156.
  295. Kato-Kataoka A, Nishida K, Takada M, et al. Fermented Milk Containing Lactobacillus casei Strain Shirota Preserves the Diversity of the Gut Microbiota and Relieves Abdominal Dysfunction in Healthy Medical Students Exposed to Academic Stress. Appl Environ Microbiol. Jun 15 2016;82(12):3649-3658.
  296. Andersson H, Tullberg C, Ahrne S, et al. Oral Administration of Lactobacillus plantarum 299v Reduces Cortisol Levels in Human Saliva during Examination Induced Stress: A Randomized, Double-Blind Controlled Trial. Int J Microbiol. 2016;2016:8469018.
  297. Messaoudi M, Lalonde R, Violle N, et al. Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. Br J Nutr. Mar 2011;105(5):755-764.
  298. Allen AP, Hutch W, Borre YE, et al. Bifidobacterium longum 1714 as a translational psychobiotic: modulation of stress, electrophysiology and neurocognition in healthy volunteers. Transl Psychiatry. Nov 1 2016;6(11):e939.
  299. Schmidt K, Cowen PJ, Harmer CJ, Tzortzis G, Errington S, Burnet PW. Prebiotic intake reduces the waking cortisol response and alters emotional bias in healthy volunteers. Psychopharmacology (Berl). May 2015;232(10):1793-1801.
  300. Gamble KL, Berry R, Frank SJ, Young ME. Circadian clock control of endocrine factors. Nat Rev Endocrinol. Aug 2014;10(8):466-475.
  301. Hardeland R. Melatonin in aging and disease -multiple consequences of reduced secretion, options and limits of treatment. Aging Dis. Apr 2012;3(2):194-225.
  302. Tsang AH, Barclay JL, Oster H. Interactions between endocrine and circadian systems. J Mol Endocrinol. Feb 2014;52(1):R1-16.
  303. Burman D. Sleep Disorders: Circadian Rhythm Sleep-Wake Disorders. FP Essent. Sep 2017;460:33-36.
  304. Xie Z, Chen F, Li WA, et al. A review of sleep disorders and melatonin. Neurol Res. Jun 2017;39(6):559-565.
  305. Auld F, Maschauer EL, Morrison I, Skene DJ, Riha RL. Evidence for the efficacy of melatonin in the treatment of primary adult sleep disorders. Sleep Med Rev. Aug 2017;34:10-22.
  306. Zisapel N. New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation. Br J Pharmacol. Jan 10 2018.
  307. Pawlikowski M, Kolomecka M, Wojtczak A, Karasek M. Effects of six months melatonin treatment on sleep quality and serum concentrations of estradiol, cortisol, dehydroepiandrosterone sulfate, and somatomedin C in elderly women. Neuro Endocrinol Lett. Apr 2002;23 Suppl 1:17-19.
  308. Morales AJ, Nolan JJ, Nelson JC, Yen SS. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab. Jun 1994;78(6):1360-1367.
  309. Alhaj HA, Massey AE, McAllister-Williams RH. Effects of DHEA administration on episodic memory, cortisol and mood in healthy young men: a double-blind, placebo-controlled study. Psychopharmacology (Berl). Nov 2006;188(4):541-551.
  310. Liao LY, He YF, Li L, et al. A preliminary review of studies on adaptogens: comparison of their bioactivity in TCM with that of ginseng-like herbs used worldwide. Chin Med. 2018;13:57.
  311. Panossian A. Understanding adaptogenic activity: specificity of the pharmacological action of adaptogens and other phytochemicals. Ann N Y Acad Sci. Aug 2017;1401(1):49-64.
  312. Panossian A, Wikman G. Effects of Adaptogens on the Central Nervous System and the Molecular Mechanisms Associated with Their Stress-Protective Activity. Pharmaceuticals (Basel). Jan 19 2010;3(1):188-224.
  313. Lee YJ, Lee YM, Lee CK, Jung JK, Han SB, Hong JT. Therapeutic applications of compounds in the Magnolia family. Pharmacol Ther. May 2011;130(2):157-176.
  314. Xu Q, Yi LT, Pan Y, et al. Antidepressant-like effects of the mixture of honokiol and magnolol from the barks of Magnolia officinalis in stressed rodents. Prog Neuropsychopharmacol Biol Psychiatry. Apr 1 2008;32(3):715-725.
  315. Li LF, Lu J, Li XM, et al. Antidepressant-like effect of magnolol on BDNF up-regulation and serotonergic system activity in unpredictable chronic mild stress treated rats. Phytother Res. Aug 2012;26(8):1189-1194.
  316. Wang C, Gan D, Wu J, Liao M, Liao X, Ai W. Honokiol Exerts Antidepressant Effects in Rats Exposed to Chronic Unpredictable Mild Stress by Regulating Brain Derived Neurotrophic Factor Level and Hypothalamus-Pituitary-Adrenal Axis Activity. Neurochem Res. Aug 2018;43(8):1519-1528.
  317. Cheng J, Dong S, Yi L, Geng D, Liu Q. Magnolol abrogates chronic mild stress-induced depressive-like behaviors by inhibiting neuroinflammation and oxidative stress in the prefrontal cortex of mice. Int Immunopharmacol. Jun 2018;59:61-67.
  318. Talbott SM, Talbott JA, Pugh M. Effect of Magnolia officinalis and Phellodendron amurense (Relora(R)) on cortisol and psychological mood state in moderately stressed subjects. J Int Soc Sports Nutr. 2013;10(1):37.
  319. Garrison R, Chambliss WG. Effect of a proprietary Magnolia and Phellodendron extract on weight management: a pilot, double-blind, placebo-controlled clinical trial. Altern Ther Health Med. Jan-Feb 2006;12(1):50-54.
  320. Kalman DS, Feldman S, Feldman R, Schwartz HI, Krieger DR, Garrison R. Effect of a proprietary Magnolia and Phellodendron extract on stress levels in healthy women: a pilot, double-blind, placebo-controlled clinical trial. Nutr J. Apr 21 2008;7:11.
  321. Cohen MM. Tulsi - Ocimum sanctum: A herb for all reasons. J Ayurveda Integr Med. Oct-Dec 2014;5(4):251-259.
  322. Jamshidi N, Cohen MM. The Clinical Efficacy and Safety of Tulsi in Humans: A Systematic Review of the Literature. Evid Based Complement Alternat Med. 2017;2017:9217567.
  323. Sampath S, Mahapatra SC, Padhi MM, Sharma R, Talwar A. Holy basil (Ocimum sanctum Linn.) leaf extract enhances specific cognitive parameters in healthy adult volunteers: A placebo controlled study. Indian J Physiol Pharmacol. Jan-Mar 2015;59(1):69-77.
  324. Saxena RC, Singh R, Kumar P, et al. Efficacy of an Extract of Ocimum tenuiflorum (OciBest) in the Management of General Stress: A Double-Blind, Placebo-Controlled Study. Evid Based Complement Alternat Med. 2012;2012:894509.
  325. Bhattacharyya D, Sur TK, Jana U, Debnath PK. Controlled programmed trial of Ocimum sanctum leaf on generalized anxiety disorders. Nepal Med Coll J. Sep 2008;10(3):176-179.
  326. Singh N, Bhalla M, de Jager P, Gilca M. An overview on ashwagandha: a Rasayana (rejuvenator) of Ayurveda. Afr J Tradit Complement Altern Med. 2011;8(5 Suppl):208-213.
  327. Yenisetti SC, Manjunath MJ, Muralidhara C. Neuropharmacological Properties of Withania somnifera - Indian Ginseng: An Overview on Experimental Evidence with Emphasis on Clinical Trials and Patents. Recent Pat CNS Drug Discov. 2016;10(2):204-215.
  328. Dar PA, Singh LR, Kamal MA, Dar TA. Unique Medicinal Properties of Withania somnifera: Phytochemical Constituents and Protein Component. Curr Pharm Des. 2016;22(5):535-540.
  329. Dar NJ, Hamid A, Ahmad M. Pharmacologic overview of Withania somnifera, the Indian Ginseng. Cell Mol Life Sci. Dec 2015;72(23):4445-4460.
  330. Pratte MA, Nanavati KB, Young V, Morley CP. An alternative treatment for anxiety: a systematic review of human trial results reported for the Ayurvedic herb ashwagandha (Withania somnifera). J Altern Complement Med. Dec 2014;20(12):901-908.
  331. Chandrasekhar K, Kapoor J, Anishetty S. A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults. Indian J Psychol Med. Jul 2012;34(3):255-262.
  332. Choudhary D, Bhattacharyya S, Joshi K. Body Weight Management in Adults Under Chronic Stress Through Treatment With Ashwagandha Root Extract: A Double-Blind, Randomized, Placebo-Controlled Trial. J Evid Based Complementary Altern Med. Jan 2017;22(1):96-106.
  333. Aguiar S, Borowski T. Neuropharmacological review of the nootropic herb Bacopa monnieri. Rejuvenation Res. Aug 2013;16(4):313-326.
  334. Sheikh N, Ahmad A, Siripurapu KB, Kuchibhotla VK, Singh S, Palit G. Effect of Bacopa monniera on stress induced changes in plasma corticosterone and brain monoamines in rats. J Ethnopharmacol. May 22 2007;111(3):671-676.
  335. Liu X, Liu F, Yue R, et al. The antidepressant-like effect of bacopaside I: possible involvement of the oxidative stress system and the noradrenergic system. Pharmacol Biochem Behav. Sep 2013;110:224-230.
  336. Kumar SS, Saraswathi P, Vijayaraghavan R. Effect of bacopa monniera on cold stress induced neurodegeneration in hippocampus of wistar rats: a histomorphometric study. J Clin Diagn Res. Jan 2015;9(1):Af05-07.
  337. Rai D, Bhatia G, Palit G, Pal R, Singh S, Singh HK. Adaptogenic effect of Bacopa monniera (Brahmi). Pharmacol Biochem Behav. Jul 2003;75(4):823-830.
  338. Chowdhuri DK, Parmar D, Kakkar P, Shukla R, Seth PK, Srimal RC. Antistress effects of bacosides of Bacopa monnieri: modulation of Hsp70 expression, superoxide dismutase and cytochrome P450 activity in rat brain. Phytother Res. Nov 2002;16(7):639-645.
  339. Banerjee R, Hazra S, Ghosh AK, Mondal AC. Chronic administration of bacopa monniera increases BDNF protein and mRNA expressions: a study in chronic unpredictable stress induced animal model of depression. Psychiatry Investig. Jul 2014;11(3):297-306.
  340. Hazra S, Kumar S, Saha GK, Mondal AC. Reversion of BDNF, Akt and CREB in Hippocampus of Chronic Unpredictable Stress Induced Rats: Effects of Phytochemical, Bacopa Monnieri. Psychiatry Investig. Jan 2017;14(1):74-80.
  341. Zu X, Zhang M, Li W, et al. Antidepressant-like Effect of Bacopaside I in Mice Exposed to Chronic Unpredictable Mild Stress by Modulating the Hypothalamic-Pituitary-Adrenal Axis Function and Activating BDNF Signaling Pathway. Neurochem Res. Nov 2017;42(11):3233-3244.
  342. Kumar S, Mondal AC. Neuroprotective, Neurotrophic and Anti-oxidative Role of Bacopa monnieri on CUS Induced Model of Depression in Rat. Neurochem Res. Nov 2016;41(11):3083-3094.
  343. Phulara SC, Shukla V, Tiwari S, Pandey R. Bacopa monnieri promotes longevity in Caenorhabditis elegans under stress conditions. Pharmacogn Mag. Apr-Jun 2015;11(42):410-416.
  344. Benson S, Downey LA, Stough C, Wetherell M, Zangara A, Scholey A. An acute, double-blind, placebo-controlled cross-over study of 320 mg and 640 mg doses of Bacopa monnieri (CDRI 08) on multitasking stress reactivity and mood. Phytother Res. Apr 2014;28(4):551-559.
  345. Calabrese C, Gregory WL, Leo M, Kraemer D, Bone K, Oken B. Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial. J Altern Complement Med. Jul 2008;14(6):707-713.
  346. Shakeri A, Sahebkar A, Javadi B. Melissa officinalis L. - A review of its traditional uses, phytochemistry and pharmacology. J Ethnopharmacol. Jul 21 2016;188:204-228.
  347. Miraj S, Rafieian K, Kiani S. Melissa officinalis L: A Review Study With an Antioxidant Prospective. J Evid Based Complementary Altern Med. Jul 2017;22(3):385-394.
  348. Scholey A, Gibbs A, Neale C, et al. Anti-stress effects of lemon balm-containing foods. Nutrients. Oct 30 2014;6(11):4805-4821.
  349. Kennedy DO, Little W, Scholey AB. Attenuation of laboratory-induced stress in humans after acute administration of Melissa officinalis (Lemon Balm). Psychosom Med. Jul-Aug 2004;66(4):607-613.
  350. Cases J, Ibarra A, Feuillere N, Roller M, Sukkar SG. Pilot trial of Melissa officinalis L. leaf extract in the treatment of volunteers suffering from mild-to-moderate anxiety disorders and sleep disturbances. Med J Nutrition Metab. Dec 2011;4(3):211-218.
  351. Haybar H, Javid AZ, Haghighizadeh MH, Valizadeh E, Mohaghegh SM, Mohammadzadeh A. The effects of Melissa officinalis supplementation on depression, anxiety, stress, and sleep disorder in patients with chronic stable angina. Clin Nutr ESPEN. Aug 2018;26:47-52.
  352. Dolatabadi F, Abdolghaffari AH, Farzaei MH, et al. The Protective Effect of Melissa officinalis L. in Visceral Hypersensitivity in Rat Using 2 Models of Acid-induced Colitis and Stress-induced Irritable Bowel Syndrome: A Possible Role of Nitric Oxide Pathway. J Neurogastroenterol Motil. Jul 30 2018;24(3):490-501.
  353. Gohari AR, Saeidnia S, Mahmoodabadi MK. An overview on saffron, phytochemicals, and medicinal properties. Pharmacogn Rev. Jan-Jun 2013;7(13):61-66.
  354. Shafiee M, Arekhi S, Omranzadeh A, Sahebkar A. Saffron in the treatment of depression, anxiety and other mental disorders: Current evidence and potential mechanisms of action. J Affect Disord. Feb 2018;227:330-337.
  355. Pitsikas N. Constituents of Saffron (Crocus sativus L.) as Potential Candidates for the Treatment of Anxiety Disorders and Schizophrenia. Molecules. Mar 02 2016;21(3):303.
  356. Ghadrdoost B, Vafaei AA, Rashidy-Pour A, et al. Protective effects of saffron extract and its active constituent crocin against oxidative stress and spatial learning and memory deficits induced by chronic stress in rats. Eur J Pharmacol. Sep 30 2011;667(1-3):222-229.
  357. Dastgerdi AH, Radahmadi M, Pourshanazari AA, Dastgerdi HH. Effects of Crocin on Learning and Memory in Rats Under Chronic Restraint Stress with Special Focus on the Hippocampal and Frontal Cortex Corticosterone Levels. Adv Biomed Res. 2017;6:157.
  358. Bandegi AR, Rashidy-Pour A, Vafaei AA, Ghadrdoost B. Protective Effects of Crocus Sativus L. Extract and Crocin against Chronic-Stress Induced Oxidative Damage of Brain, Liver and Kidneys in Rats. Adv Pharm Bull. Dec 2014;4(Suppl 2):493-499.
  359. Farkhondeh T, Samarghandian S, Samini F, Sanati AR. Protective Effects of Crocetin on Depression-like Behavior Induced by Immobilization in Rat. CNS Neurol Disord Drug Targets. 2018;17(5):361-369.
  360. Kell G, Rao A, Beccaria G, Clayton P, Inarejos-Garcia AM, Prodanov M. affron((R)) a novel saffron extract (Crocus sativus L.) improves mood in healthy adults over 4 weeks in a double-blind, parallel, randomized, placebo-controlled clinical trial. Complement Ther Med. Aug 2017;33:58-64.
  361. Xu W, Choi HK, Huang L. State of Panax ginseng Research: A Global Analysis. Molecules. Sep 11 2017;22(9).
  362. Kim JH, Yi YS, Kim MY, Cho JY. Role of ginsenosides, the main active components of Panax ginseng, in inflammatory responses and diseases. J Ginseng Res. Oct 2017;41(4):435-443.
  363. Kim KH, Lee D, Lee HL, Kim CE, Jung K, Kang KS. Beneficial effects of Panax ginseng for the treatment and prevention of neurodegenerative diseases: past findings and future directions. J Ginseng Res. Jul 2018;42(3):239-247.
  364. Kim JH. Pharmacological and medical applications of Panax ginseng and ginsenosides: a review for use in cardiovascular diseases. J Ginseng Res. Jul 2018;42(3):264-269.
  365. Lee YM, Yoon H, Park HM, Song BC, Yeum KJ. Implications of red Panax ginseng in oxidative stress associated chronic diseases. J Ginseng Res. Apr 2017;41(2):113-119.
  366. Flanagan SD, DuPont WH, Caldwell LK, et al. The Effects of a Korean Ginseng, GINST15, on Hypo-Pituitary-Adrenal and Oxidative Activity Induced by Intense Work Stress. J Med Food. Jan 2018;21(1):104-112.
  367. Huang L, Zhao H, Huang B, Zheng C, Peng W, Qin L. Acanthopanax senticosus: review of botany, chemistry and pharmacology. Pharmazie. Feb 2011;66(2):83-97.
  368. Ishaque S, Shamseer L, Bukutu C, Vohra S. Rhodiola rosea for physical and mental fatigue: a systematic review. BMC Complement Altern Med. May 29 2012;12:70.
  369. Li Y, Pham V, Bui M, et al. Rhodiola rosea L.: an herb with anti-stress, anti-aging, and immunostimulating properties for cancer chemoprevention. Curr Pharmacol Rep. Dec 2017;3(6):384-395.
  370. Chiang HM, Chen HC, Wu CS, Wu PY, Wen KC. Rhodiola plants: Chemistry and biological activity. J Food Drug Anal. Sep 2015;23(3):359-369.
  371. Kasper S, Dienel A. Multicenter, open-label, exploratory clinical trial with Rhodiola rosea extract in patients suffering from burnout symptoms. Neuropsychiatr Dis Treat. 2017;13:889-898.
  372. Lekomtseva Y, Zhukova I, Wacker A. Rhodiola rosea in Subjects with Prolonged or Chronic Fatigue Symptoms: Results of an Open-Label Clinical Trial. Complement Med Res. 2017;24(1):46-52.
  373. Cropley M, Banks AP, Boyle J. The Effects of Rhodiola rosea L. Extract on Anxiety, Stress, Cognition and Other Mood Symptoms. Phytother Res. Dec 2015;29(12):1934-1939.
  374. Amsterdam JD, Panossian AG. Rhodiola rosea L. as a putative botanical antidepressant. Phytomedicine. Jun 15 2016;23(7):770-783.
  375. Concerto C, Infortuna C, Muscatello MRA, et al. Exploring the effect of adaptogenic Rhodiola Rosea extract on neuroplasticity in humans. Complement Ther Med. Dec 2018;41:141-146.
  376. Variya BC, Bakrania AK, Patel SS. Emblica officinalis (Amla): A review for its phytochemistry, ethnomedicinal uses and medicinal potentials with respect to molecular mechanisms. Pharmacol Res. Sep 2016;111:180-200.
  377. Tahir I, Khan MR, Shah NA, Aftab M. Evaluation of phytochemicals, antioxidant activity and amelioration of pulmonary fibrosis with Phyllanthus emblica leaves. BMC Complement Altern Med. Oct 24 2016;16(1):406.
  378. Fatima N, Pingali U, Pilli R. Evaluation of Phyllanthus emblica extract on cold pressor induced cardiovascular changes in healthy human subjects. Pharmacognosy Res. Jan 2014;6(1):29-35.
  379. Bhattacharya A, Ghosal S, Bhattacharya SK. Antioxidant activity of tannoid principles of Emblica officinalis (amla) in chronic stress induced changes in rat brain. Indian J Exp Biol. Sep 2000;38(9):877-880.
  380. Arun S, Burawat J, Yannasithinon S, Sukhorum W, Limpongsa A, Iamsaard S. Phyllanthus emblica leaf extract ameliorates testicular damage in rats with chronic stress. J Zhejiang Univ Sci B. Dec. 2018;19(12):948-959.
  381. Dwivedi V, Lakhotia SC. Ayurvedic Amalaki Rasayana promotes improved stress tolerance and thus has anti-aging effects in Drosophila melanogaster. J Biosci. Dec 2016;41(4):697-711.
  382. Szopa A, Ekiert R, Ekiert H. Current knowledge of Schisandra chinensis (Turcz.) Baill. (Chinese magnolia vine) as a medicinal plant species: a review on the bioactive components, pharmacological properties, analytical and biotechnological studies. Phytochem Rev. 2017;16(2):195-218.
  383. Zhang M, Xu L, Yang H. Schisandra chinensis Fructus and Its Active Ingredients as Promising Resources for the Treatment of Neurological Diseases. Int J Mol Sci. Jul 6 2018;19(7).
  384. Sowndhararajan K, Deepa P, Kim M, Park SJ, Kim S. An overview of neuroprotective and cognitive enhancement properties of lignans from Schisandra chinensis. Biomed Pharmacother. Jan 2018;97:958-968.
  385. Chen WW, He RR, Li YF, Li SB, Tsoi B, Kurihara H. Pharmacological studies on the anxiolytic effect of standardized Schisandra lignans extract on restraint-stressed mice. Phytomedicine. Oct 15 2011;18(13):1144-1147.
  386. Xia N, Li J, Wang H, Wang J, Wang Y. Schisandra chinensis and Rhodiola rosea exert an anti-stress effect on the HPA axis and reduce hypothalamic c-Fos expression in rats subjected to repeated stress. Exp Ther Med. Jan 2016;11(1):353-359.
  387. Yan T, Xu M, Wan S, et al. Schisandra chinensis produces the antidepressant-like effects in repeated corticosterone-induced mice via the BDNF/TrkB/CREB signaling pathway. Psychiatry Res. Sep 30 2016;243:135-142.
  388. Zhou X, Gong Z, Su Y, Lin J, Tang K. Cordyceps fungi: natural products, pharmacological functions and developmental products. J Pharm Pharmacol. Mar 2009;61(3):279-291.
  389. Olatunji OJ, Tang J, Tola A, Auberon F, Oluwaniyi O, Ouyang Z. The genus Cordyceps: An extensive review of its traditional uses, phytochemistry and pharmacology. Fitoterapia. Sep 2018;129:293-316.
  390. Liu Y, Wang J, Wang W, Zhang H, Zhang X, Han C. The Chemical Constituents and Pharmacological Actions of Cordyceps sinensis. Evid Based Complement Alternat Med. 2015;2015:575063.
  391. Tianzhu Z, Shihai Y, Juan D. Antidepressant-like effects of cordycepin in a mice model of chronic unpredictable mild stress. Evid Based Complement Alternat Med. 2014;2014:438506.
  392. Rossi P, Buonocore D, Altobelli E, et al. Improving Training Condition Assessment in Endurance Cyclists: Effects of Ganoderma lucidum and Ophiocordyceps sinensis Dietary Supplementation. Evid Based Complement Alternat Med. 2014;2014:979613.